GlassScriptPhysician profile
Mazen Iskandar
NPI 1861783938
$58,135.70
in general payments reported to CMS, 2019-2025
21 companies · $2,062 in 2025
The $2,062 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.95 · 2020: $2,197 · 2021: $25K · 2022: $17K · 2023: $6,972 · 2024: $5,372 · 2025: $2,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Travel and Lodging: $2,249 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,450.00 |
| Travel and Lodging | $2,248.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $706.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $52,499.41 | 2019-2025 | Da Vinci Surgical System |
| Covidien LP | $2,106.31 | 2020 | |
| Stryker Corporation | $1,314.29 | 2022-2023 | Monterey Al, Canyon Retractor Systems, Everest Spinal System |
| Nuvasive, INC. | $1,235.22 | 2023 | Alif |
| Allergan, INC. | $234.94 | 2022 | |
| Abbvie INC. | $154.46 | 2024 | |
| Ethicon US, LLC | $116.91 | 2019-2023 | Echelon Flex |
| Integra Lifesciences Corporation | $114.28 | 2021-2022 | |
| Acell, INC. | $61.33 | 2020 | |
| Medtronic, INC. | $55.78 | 2023 | Ligasure, Interstim |
| Access Pro Medical, LLC | $36.81 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $33.67 | 2025 | Phasix Mesh |
| Pacira Pharmaceuticals Incorporated | $28.22 | 2025 | Exparel |
| Vertex Pharmaceuticals Incorporated | $25.63 | 2024 | |
| Tela Bio, INC. | $21.49 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $19.29 | 2021-2022 | |
| Becton, Dickinson and Company | $17.94 | 2021 | |
| Smith+Nephew, INC. | $17.80 | 2024 | Pico 7 |
| W. L. Gore & Associates, INC. | $17.18 | 2023 | Gore Enform Preperitoneal Biomaterial |
| Merck Sharp & Dohme LLC | $12.70 | 2021 | |
| Davol INC. | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mazen Iskandar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.